The GAVI Vaccine Alliance has signed an advanced purchase agreement with Johnson & Johnson for 200 million doses of its COVID-19 vaccine for the COVAX vaccine-sharing programme, it said in a statement on Friday.
By Reuters Staff
3 Min Read
SHANGHAI, May 6 (Reuters) - Shares in Chinese vaccine makers slumped on Thursday after U.S. President Joe Biden’s support for a proposed waiver of intellectual property rights on COVID-19 vaccines sent investors scrambling to reconsider high valuations.
The Shanghai shares of CanSino Biologics Inc, a single-dose COVID-19 vaccine maker, tumbled as much as 16.91%. The company’s Hong Kong shares fell even further, at one point diving nearly 22%.
Shares of Shanghai Fosun Pharmaceutical Group fell by the 10% daily limit, as the CSI300 healthcare sub-index dropped more than 5%.
On Wednesday, Biden indicated his support for a waiver amid growing concern that big outbreaks in India could allow the rise of vaccine-resistant strains of the deadly virus, undermining a global recovery.
3 Min Read
ISLAMABAD (Reuters) -Pakistan has purchased 13 million doses of COVID-19 vaccine from three Chinese companies and expects to receive them in the next two months, its health minister said on Thursday.
FILE PHOTO: A resident receives a dose of coronavirus disease (COVID-19) vaccine, at a vaccination center in Karachi, Pakistan March 22, 2021. REUTERS/Akhtar Soomro
The vaccines were procured from Sinopharm, CanSinoBio and Sinovac, Faisal Sultan told Reuters.
They will supplement around 2.4 million shots from the COVAX programme for poorer nations that are expected to arrive during that period.
“We will be continuously procuring from all available sources across the world,” Sultan said. “For now, China remains the primary source for vaccines to meet our present and ongoing needs but all our options are open for effective and safe vaccines.”
U.S. weekly jobless claims decline further Indexes down: Dow 0.94%, S&P 500 0.92%, Nasdaq 0.94% (Adds prices after 4 p.m. market close)
NEW YORK, April 22 (Reuters) - U.S. stocks dived on Thursday on reports President Joe Biden planned to almost double the capital gains tax, news analysts said provided an excuse to take profits in a directionless market ahead of big tech’s earnings next week.
The three main indexes on Wall Street also fell on reports that Biden planned to raise income taxes on the wealthy, a proposal some said would be hard to pass in Congress.
“If it had a chance of passing, we’d be down 2,000 points,” said Thomas Hayes, chairman and managing member at hedge fund Great Hill Capital LLC.